DNA mismatch repair and cancer

Mutation Research - Reviews in Mutation Research

Volumn 488, Issue 1, 2001, Pages 77-85

  Peltomäki, Päivi ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Carcinogenesis; Colon cancer; DNA mismatch repair; HNPCC

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; CYCLOOXYGENASE 2 INHIBITOR;

ALKYLATION; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME PAIRING; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; GENE INACTIVATION; GENE MUTATION; HUMAN; MICROSATELLITE INSTABILITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS;

EID: 0035101436     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00058-2     Document Type: Review

References (70)

1. Eukaryotic mismatch repair
2. Mammalian DNA mismatch repair
3. Mismatch repair defects in cancer
4. Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair
5. Novel dominant mutations in Saccharomyces cerevisiae MSH6
6. hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA
7. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis
8. Cancer risk in mutation carriers of DNA mismatch repair genes
9. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study
10. Mutations predisposing to hereditary nonpolyposis colorectal cancer
11. Familial endometrial cancer in female carriers of MSH6 germline mutations
12. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers
13. Variable mutation frequencies in coding repeats of TCF4 and other target genes in colon, gastric and endometrial carcinoma showing microsatellite instability
14. Mouse models for hereditary nonpolyposis colorectal cancer
15. Genetic pathways to colorectal cancer
16. Mutator phenotypes in human colorectal carcinoma cell lines
17. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer
18. APC mutations in colorectal tumors with mismatch repair deficiency
19. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer
20. Development of international criteria for the determination of microsatellite instability in colorectal cancer
21. Lessons from hereditary colorectal cancer
22. MSH2 and MLH1 mutations in sporadic replication-error positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis
23. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers
24. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cells
25. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
26. Biallelic inactivation of hMLH1 by epigenetic silencing, a novel mechanism causing human MSI cancers
27. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer
28. Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer
29. Frameshift mutator mutations
30. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred
31. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer
32. Germ-line msh6 mutations in colorectal cancer families
33. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations
34. The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression
35. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer
36. The molecular basis of Turcot's syndrome
37. Somatic mutation of hPMS2 as a possible cause of sporadic human colon cancer with microsatellite instability
38. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
39. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
40. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability
41. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history
42. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences
43. MSH2 deficient mice are viable and susceptible to lymphoid tumours
44. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer
45. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over
46. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair
47. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility
48. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions
49. Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis
50. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis
51. -/-;Min mice
52. Selective recognition of a cis-platin-DNA adduct by human mismatch repair proteins
53. Human MutSα specifically binds to DNA containing aminofluorene and acetylaminofluorene adducts
54. Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation
55. Genomic instability and tolerance to alkylating agents
56. Evidence for a connection between the mismatch repair system and the G2 cell cycle checkpoint
57. hMutSα and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
58. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
59. Transcription-coupled repair deficiency and mutations in human mismatch repair genes
60. Physical interaction between components of DNA mismatch repair and nucleotide excision repair
61. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair
62. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma
63. Comparative genomic in situ hybridization of colon carcinomas with replication error
64. Meiotic gene conversion mutants in Saccharomyces cerevisiae. I. Isolation and characterization of pms-1 and pms-2
65. Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin
66. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of cyclooxygenase 2 (COX2)
67. Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection
68. Reduced COX2 protein in colorectal cancer with defective mismatch repair
69. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers
70. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors